Today: 29 January 2026
Subscribe
Browse Category

NASDAQ:SYRE News 2 January 2026 - 5 January 2026

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

Spyre Therapeutics stock drops as biotech slides — what SYRE investors watch next

New York, January 5, 2026, 15:09 EST — Regular session Shares of Spyre Therapeutics Inc fell 2.7% to $29.75 in afternoon trading on Monday, extending a choppy start to the year for smaller biotechnology names. The stock traded between $28.02 and $30.75, with about 0.63 million shares changing hands. The decline tracked weakness across the biotech complex, with the SPDR…
5 January 2026
····
Spyre Therapeutics stock slid 6.6% into the weekend — here’s what matters before Monday’s open

Spyre Therapeutics stock slid 6.6% into the weekend — here’s what matters before Monday’s open

NEW YORK, Jan 4, 2026, 11:15 ET — Market closed Spyre Therapeutics shares fell 6.6% to $30.58 on Friday, then ticked up about 2% in after-hours trading, as U.S. markets headed into the weekend. Yahoo Finance With markets shut on Sunday, the Friday move leaves Spyre starting the new week with momentum tilted lower — a reminder that development-stage biotech…
4 January 2026
·····
Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

Spyre Therapeutics stock sinks 7% today: what’s pressuring SYRE and what investors watch next

NEW YORK, Jan 2, 2026, 14:37 ET — Regular session Shares of Spyre Therapeutics, Inc. slid about 7% on Friday, falling to $30.48 in afternoon trading after touching a session low of $30.11. The stock opened at $32.76 and was last down $2.28 on the day. The move left Spyre underperforming the broader biotech tape, with the SPDR S&P Biotech…
2 January 2026
·····

Stock Market Today

  • Euronext Dublin GEM Notice Highlights Market Data Providers
    January 29, 2026, 4:07 AM EST. Euronext Dublin released a GEM notice outlining key market data providers including ICE Data Services and FactSet, both integral in supplying reference and market data. FactSet also provides the CUSIP Database used for securities identification, while SEC filings and related documents come via Quartr. TradingView supports broader market analytics. These contributors underpin transparency and data accuracy for market participants on Euronext Dublin's Growth Enterprise Market (GEM).
Go toTop